Standard BioTools Inc. Common Stock

Standard BioTools Stock Surges on Strategic Sale of SomaLogic

Standard BioTools shares are trading higher after announcing the strategic sale of SomaLogic to Illumina for up to $425 million, simplifying operations and advancing towards profitability.